Related Experiment Video
Updated: Nov 29, 2025

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Frequency Of Depression Among Patients With Chronic Liver Disease
Adil Naseer Khan1, Mohammad Arshad Abbassi2, Asad Gandapur1
1Department of Gastroenterology, Ayub Medical College, Abbottabad, Pakistan.
Depression affects over a third of patients with chronic liver disease (CLD). This mental health condition is linked to how long patients have had CLD and abnormal liver enzyme levels.
Area of Science:
- Hepatology
- Psychiatry
- Clinical Medicine
Background:
- Psychiatric co-morbidities are common in chronic liver disease (CLD).
- Patients with CLD often experience anxiety, depression, sleep disturbances, behavioral disorders, and cognitive deficits.
- Major depression is a significant concern in the CLD population.
Purpose of the Study:
- To determine the frequency of major depression in patients diagnosed with chronic liver disease.
- To investigate the association between depression and demographic/clinical factors in CLD patients.
Main Methods:
- A descriptive cross-sectional study was conducted with 111 CLD patients.
- Data collected via medical history, physical examination, and the Hospital Anxiety and Depression Scale (HADS-D) questionnaire.
- Statistical analysis included descriptive statistics, Chi-Square tests, and stratification by age, gender, and CLD duration.
Main Results:
- 34.2% of CLD patients (38 out of 111) exhibited depression based on HADS-D scores.
- Depression showed a statistically significant association with the duration of chronic liver disease (p<0.05).
- Increased serum ALT levels were also significantly associated with depression in CLD patients.
Conclusions:
- Depression is a prevalent condition among patients with chronic liver disease.
- The duration of CLD and elevated liver enzymes are significantly associated with depression.
- These findings highlight the importance of screening for depression in CLD patients.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Depressive Disorders: MDD and Dysthymia